Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Diabetes: Daily Aspirin or Other Antiplatelet for Diabetes Patients with Ischemic Vascular Disease (IVD) Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 29 Clinics in the Bellin Health health system


The results below represent the care of 607 patients with Diabetes. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
ALGOMA NURSING HOME PROGRAM

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH CRIVITZ

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH DAGGETT

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC ALGOMA

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC ASHWAUBENON
N=199
97.49 %
View Historical Data
BELLIN HEALTH FMC ASHWAUBENON IM AND PEDIATRICS

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC BELLEVUE

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC BONDUEL

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC BRILLION

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC DE PERE EAST
N=112
97.32 %
View Historical Data
BELLIN HEALTH FMC DE PERE WEST

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC DENMARK

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC ESCANABA

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC HOWARD

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC IRON MOUNTAIN
N=105
96.19 %
View Historical Data
BELLIN HEALTH FMC KEWAUNEE

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC LUXEMBURG

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC MANITOWOC

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC OCONTO

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC OCONTO FALLS

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC PULASKI

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC SEYMOUR

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC SURING

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC WEBSTER AVE AND CLINICA HISPANA

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC WRIGHTSTOWN

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH MARINETTE
N=191
98.43 %
BELLIN HEALTH MENOMINEE

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH PESHTIGO

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH STURGEON BAY

The number of patients or providers is too small for
purposes of reliably reporting performance

Based on trials involving other secondary prevention therapies, the American College of Cardiology (ACC) and the American Heart Assocation (AHA) recommends aspirin in all patients, unless contraindicated, with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. The ACC and AHA also recommend the use of other antiplatelet agents based on disease type and clinical conditions. The American Diabetes Association (ADA) supports this recommendation as a secondary prevention strategy for type 1 or type 2 diabetes with a history of cardiovascular disease.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.